Published in Bull World Health Organ on January 01, 1978
Viral immunodiagnosis. Yale J Biol Med (1980) 0.89
Single radial complement fixation test for assaying antibody to influenza virus type-specific antigens. J Clin Microbiol (1983) 0.80
Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J (1968) 5.54
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Application of the passive haemolysis test for the determination of rubella virus antibodies. Acta Pathol Microbiol Scand B (1975) 2.66
Single-radial-complement-fixation: a new immunodiffusion technique. 2. Assay of the antibody response to the internal antigens (MP and NP) of influenza A virus in human sera after vaccination and infection. Dev Biol Stand (1978) 0.95
Parenteral influenza vaccination induces a rapid systemic and local immune response. J Infect Dis (1995) 2.67
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine (1994) 2.09
The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis (1999) 1.58
Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. Scand J Immunol (2005) 1.28
Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J Infect Dis (1998) 1.24
Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy. J Clin Microbiol (1989) 1.10
Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection. J Hyg (Lond) (1981) 1.09
Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J Clin Microbiol (1989) 1.02
Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. Antiviral activities of the antibodies in biological systems. Acta Pathol Microbiol Scand B (1980) 0.98
Antigenic variants of influenza A virus obtained in vitro. Bull World Health Organ (1976) 0.98
Cross-reaction but no avidity change of the serum antibody response after influenza vaccination. Vaccine (1995) 0.96
A monoclonal antibody inhibiting human placental Fc gamma-receptor activity. Int Arch Allergy Appl Immunol (1984) 0.95
Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. Scand J Immunol (2002) 0.94
A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice. Scand J Immunol (2007) 0.93
Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol (1996) 0.92
The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. J Infect Dis (1999) 0.92
Impact of influenza vaccine formulation with a detailed analysis of the cytokine response. Scand J Immunol (2006) 0.91
Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. Scand J Immunol (2005) 0.90
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant. Dev Biol Stand (1998) 0.88
Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study. Vaccine (1998) 0.87
Haemagglutination-inhibition antibodies in human sera to an antigenic mutant of influenza A/Texas/1/77 (H3N2) virus obtained in vitro. Acta Pathol Microbiol Scand B (1980) 0.86
IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination. J Infect Dis (1995) 0.85
The effect of zanamivir treatment on the early immune response to influenza vaccination. Vaccine (2001) 0.81
Monoclonal antibodies evoked by the free oligopeptide (Gly)5 reacting specifically with peptidoglycan from staphylococci. J Immunol Methods (1987) 0.79
Monoclonal antibodies to the h1 agglutinogen from Staphylococcus aureus 17A. Serological testing with type strains. Acta Pathol Microbiol Immunol Scand B (1984) 0.78
The immunogenicity of a cell-derived H7N1 split influenza virion vaccine in mice. Scand J Immunol (2009) 0.77
Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients. Acta Neurol Scand (1994) 0.77
Recommendations of the 7th European Meeting of Influenza and Its Prevention. Eur J Epidemiol (1994) 0.76
Intrathecal synthesis of antibodies to staphylococcal antigens in multiple sclerosis patients. Acta Pathol Microbiol Immunol Scand C (1986) 0.75
Antibodies to lipoteichoic acid from Staphylococcus aureus. Specificity of murine monoclonal and human antibodies. Acta Pathol Microbiol Immunol Scand C (1985) 0.75
[Influenza strategy]. Tidsskr Nor Laegeforen (1978) 0.75
Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 1. Preparation of antibodies and in vitro studies. Acta Pathol Microbiol Scand B (1979) 0.75
Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 virus. 3. Selection of antigenic variations in vitro and in vivo. Acta Pathol Microbiol Scand B (1980) 0.75
[Use of influenza vaccine in Norway]. Tidsskr Nor Laegeforen (1996) 0.75
Reactivity of rabbit IgG-fragments in single-radial-immunodiffusion. Acta Pathol Microbiol Scand B (1976) 0.75